New or novel psychoactive substances (NPS), also known as "designer drugs," are synthetic compounds that mimic the effects of traditional drugs like opioids, cannabinoids, and stimulants. They frequently evade legal detection due to their rapidly changing chemical structures. In both clinical and forensic settings, timely and accurate detection of NPS is critical, particularly in cases of overdose, intoxication, or drug-facilitated crimes.
New or novel psychoactive substances (NPS), also known as "designer drugs," are synthetic compounds that mimic the effects of traditional drugs like opioids, cannabinoids, and stimulants. They frequently evade legal detection due to their rapidly changing chemical structures. In both clinical and forensic settings, timely and accurate detection of NPS is critical, particularly in cases of overdose, intoxication, or drug-facilitated crimes.
B-One®
Third-generation Enzyme, All-in-one solution, Room Temperature Hydrolysis, High-purity recombinant enzyme, no secondary proteins.
BGTurbo®
Second-generation enzyme, High-purity recombinant enzyme, fast hydrolysis, no secondary proteins.